VASAMED, Inc.
VSMD
$0.00
$0.000.00%
| Weiss Ratings | VSMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | VSMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | VSMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.00 | |||
| Price History | VSMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -99.90% | |||
| 5-Year Total Return | -99.99% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | VSMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Oct 29, 2024 | |||
| 52-Week High Price (Date) | Oct 29, 2024 | |||
| Valuation | VSMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 8.00 | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | VSMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VSMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 952-944-5857 | |||
| Address | 7615 Golden Triangle Drive Eden Prairie, MN 55344 | |||
| Website | www.vasamed.com | |||
| Country | United States | |||
| Year Founded | 1988 | |||
| Profitability | VSMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -47.24% | |||
| Profit Margin | -56.16% | |||
| Management Effectiveness | VSMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -74.10% | |||
| Return on Equity | -- | |||
| Income Statement | VSMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 3.43M | |||
| Total Revenue (TTM) | 3.43M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 1.98M | |||
| EBITDA (TTM) | -1.47M | |||
| EBIT (TTM) | -1.62M | |||
| Net Income (TTM) | -1.93M | |||
| Net Income Avl. to Common (TTM) | -1.93M | |||
| Total Revenue Growth (Q YOY) | -7.15% | |||
| Earnings Growth (Q YOY) | 35.06% | |||
| EPS Diluted (TTM) | -0.24 | |||
| EPS Diluted Growth (Q YOY) | 35.05% | |||
| Balance Sheet | VSMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 136.80K | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 823.90K | |||
| Total Preferred Equity (Q) | 14.70 | |||
| Total Equity (Q) | -2.10M | |||
| Current Ratio (Q) | 0.333 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 2.48M | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | -16.80M | |||
| Cash Flow | VSMD - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -59.90K | |||
| Cash from Financing (TTM) | 967.60K | |||
| Net Change in Cash (TTM) | 121.90K | |||
| Levered Free Cash Flow (TTM) | -200.10K | |||
| Cash from Operations (TTM) | -785.70K | |||
